Aktiesnakken — April 2021
-
Stort tak, Helge
-
Morning:)
-
Lundbeck- se her: Lundbeck shares fell more than 7% in early trading after decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer's-type dementia.
• Lundbeck says completion of the trial is expected in the first half of 2022
• This means that the study didn't meet success stopping criteria at the interim analysis, Bank of America analysts said -
Lundbeck annoncering om at fortsætte rekrutteringen af patienter til fase III-forsøget af Rexulti til behandling af patienter med demens af Alzheimers-typen kan sandsynligvis ramme stemningen i aktien.
-
Matas/Danske Bank: Kurmål løftet med 10 pct. til 110 kr https://www.proinvestor.com/investornyt/673965/matas-danske-bank-kurmal-loftet-med-10-pct-til-110-kr
-
Aktier/åbning: Lundbeck falder tungt efter studienyt https://www.proinvestor.com/investornyt/673967/aktier-abning-lundbeck-falder-tungt-efter-studienyt
-
Aktier/middag: Lundbeck tumler baglæns i ellers lysegrønt marked https://www.proinvestor.com/investornyt/673973/aktier-middag-lundbeck-tumler-baglaens-i-ellers-lysegront-marked
-
Kahoot stiger 8 pct. i dag.
-
Søren Løntoft overrasket over det store fald i Lundbeck https://borsen.dk/nyheder/investor/analytiker-efter-dyk-i-lundbeck-aktien-markedet-havde-haabet-paa-succes-i-forsog
-
her opdateringen fra Løntoft https://data.sydbank.dk/api/investment/sydbank/publications/file/135036
-
God morgen.
-
God morgen fra Odense N
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind